The Different Guises of CVA. December SOLUM FINANCIAL financial.com

Similar documents
CVA Capital Charges: A comparative analysis. November SOLUM FINANCIAL financial.com

Counterparty Credit Risk and CVA

Calculating Counterparty Exposures for CVA

Regulatory sea change for OTC derivatives: The clearing and margining revolution May SOLUM FINANCIAL financial.com

Challenges in Managing Counterparty Credit Risk

Challenges in Counterparty Credit Risk Modelling

Basel Committee on Banking Supervision. Basel III counterparty credit risk - Frequently asked questions

CVA in Energy Trading

Hedging CVA. Jon Gregory ICBI Global Derivatives. Paris. 12 th April 2011

IFRS 13 - CVA, DVA AND THE IMPLICATIONS FOR HEDGE ACCOUNTING

The Basel Committee s December 2009 Proposals on Counterparty Risk

CVA. What Does it Achieve?

Pricing Counterparty Risk in Today s Market: Current Practices

Traded Risk & Regulation

Counterparty Credit Risk

Baseline report on solutions for the posting of non-cash collateral to central counterparties by pension scheme arrangements

Counterparty Credit Risk under Basel III

Emerging from the Crisis Building a Stronger International Financial System

Online appendices from The xva Challenge by Jon Gregory. APPENDIX 8A: LHP approximation and IRB formula

OIS and Its Impact on Modeling, Calibration and Funding of OTC Derivatives. May 31, 2012 Satyam Kancharla SVP, Client Solutions Group Numerix LLC

Counterparty Risk and CVA Survey Current market practice around counterparty risk regulation, CVA management and funding

FINCAD s Flexible Valuation Adjustment Solution

The Impact of Initial Margin

Derivative Contracts and Counterparty Risk

Credit Risk Modelling This course can also be presented in-house for your company or via live on-line webinar

The Next Steps in the xva Journey. Jon Gregory, Global Derivatives, Barcelona, 11 th May 2017 Copyright Jon Gregory 2017 page 1

Credit Risk Modelling This in-house course can also be presented face to face in-house for your company or via live in-house webinar

New challenges in interest rate derivatives valuation Simple is not just simple anymore. Guillaume Ledure Manager Advisory & Consulting Deloitte

On Credit Valuation Adjustment (CVA) under Article 456(2) of Regulation (EU) No 575/2013 (Capital Requirements Regulation CRR)

Modelling Counterparty Exposure and CVA An Integrated Approach

Credit Valuation Adjustment

Bank of Japan Workshop - Credit Value Adjustment Trends. 14 th June 2010

Funding Value Adjustments and Discount Rates in the Valuation of Derivatives

Traded Risk & Regulation

Operational and Computational Challenges in Counterparty Credit Risk

Strategies For Managing CVA Exposures

CONSULTATION PAPER ON DRAFT RTS ON TREATMENT OF CLEARING MEMBERS' EXPOSURES TO CLIENTS EBA/CP/2014/ February Consultation Paper

Consultative Document on reducing variation in credit risk-weighted assets constraints on the use of internal model approaches

Pillar 3 Disclosure (UK)

Preparing for the Fundamental Review of the Trading Book (FRTB)

Disclosure Report. Investec Limited Basel Pillar III semi-annual disclosure report

Guideline. Capital Adequacy Requirements (CAR) Chapter 4 - Settlement and Counterparty Risk. Effective Date: November 2017 / January

Counterparty Risk and CVA

Bank ALM and Liquidity Risk: Derivatives and FVA

Citigroup Global Markets Limited Pillar 3 Disclosures

Standardised Risk under Basel 3. Pardha Viswanadha, Product Management Calypso

African Bank Holdings Limited and African Bank Limited

Demystifying derivative instrument valuations: A commercial and accounting perspective

Capital Optimization Through an Innovative CVA Hedge

2nd Order Sensis: PnL and Hedging

Re: Exposure Draft Financial Instruments: Amortised Cost and Impairment

Introduction to Derivative Instruments Part 2

Deutsche Bank s response to the Basel Committee on Banking Supervision consultative document on the Fundamental Review of the Trading Book.

Strategic Integration of xva, Margining and Regulatory Risk Platforms

Implementing a cross asset class CVA and xva Framework

XVA S, CSA S & OTC CLEARING

11 th July Summary views

Basel III Final Standards: Capital requirement for bank exposures to central counterparties

African Bank Holdings Limited and African Bank Limited

FRAMEWORK FOR SUPERVISORY INFORMATION

Basel Committee on Banking Supervision. Frequently asked questions on Joint QIS exercise

Credit Valuation Adjustment An overview of the standardized method

WHITE PAPER THE EVOLUTION OF COUNTERPARTY CREDIT RISK - AN INSIDER S VIEW

EBF response to the EBA consultation on prudent valuation

September 28, Japanese Bankers Association

SCI/Fitch Solutions 2012 Global Credit and Counterparty Risk Survey. Leading Structured Finance News

ED&F MAN CAPITAL MARKETS LIMITED. Pillar 3 Disclosures Year ended 30 September 2016

TECHNICAL ADVICE ON THE TREATMENT OF OWN CREDIT RISK RELATED TO DERIVATIVE LIABILITIES. EBA/Op/2014/ June 2014.

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

African Bank Holdings Limited and African Bank Limited

Morgan Stanley International Limited Group

EFAMA reply to the EU Commission's consultation on EMIR REFIT

Assessing possible sources of systemic risk from hedge funds

The OIS and FVA relationship. Ion Mihai, PhD Client Solutions Group

Regulatory Uncleared OTC Margining

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

Supplementary Regulatory Capital Disclosure and Pillar 3 Report

African Bank Holdings Limited and African Bank Limited. Annual Public Pillar III Disclosures

Basel III: Comparison of Standardized and Advanced Approaches

P2.T6. Credit Risk Measurement & Management. Jon Gregory, The xva Challenge: Counterparty Credit Risk, Funding, Collateral, and Capital

Deutsche Bank Annual Report

Collateralized Banking

Margining and Collateral as CCR Mitigation Tools

Goldman Sachs Group UK (GSGUK) Pillar 3 Disclosures

Pillar 3 and regulatory disclosures Credit Suisse Group AG 2Q17

Fundamental Review Trading Books

Commission services staff working document: Further possible changes to the Capital Requirement Directive (CRD4)

Basel Committee on Banking Supervision. Fair value measurement and modelling: An assessment of challenges and lessons learned from the market stress

Review of Accounting Practices

Pillar 3 Regulatory Disclosure (UK) As at 31 December 2012

The Goldman Sachs Group, Inc. PILLAR 3 DISCLOSURES

Discussion Paper on Margin Requirements for non-centrally Cleared Derivatives

IFRS 13 The Impact on Derivative Valuation, Hedge Accounting and Financial Reporting. 24 September 2013 Dan Gentzel & Peter Ahlin

Risk Modeling: Lecture outline and projects. (updated Mar5-2012)

Instructions for EBA data collection exercise on CVA

Basel Committee on Banking Supervision

Review of Non-Internal Model Approaches for Measuring Counterparty Credit Risk Exposures

References: Articles to , to and of the AMF General Regulation

CHINA CONSTRUCTION BANK (ASIA) CORPORATION LIMITED. Regulatory Disclosures For the year ended 31 December 2017 (Unaudited)

Aviva Investors response to CESR s Technical Advice to the European Commission in the context of the MiFID Review: Non-equity markets transparency

Transcription:

The Different Guises of CVA December 2012 SOLUM FINANCIAL www.solum financial.com

Introduction The valuation of counterparty credit risk via credit value adjustment (CVA) has long been a consideration for banks, especially those with large over the counter (OTC) derivatives positions. The global financial crisis has increased the significance of counterparty risk and CVA as credit markets have become extremely turbulent. Changes to regulatory capital rules and accounting standards have emphasised the importance of CVA still further. Basel III capital rules require a specific capital charge for the volatility of CVA (so called CVA VaR) and IFRS 13 accounting standards make a more specific reference to the calculation of CVA as a market determined value. Controversy exists over DVA (debt value adjustment), which is the mirror image of CVA and relates to an institution s own default. Given all the importance of CVA, something that is particularly surprising is that it is not very well defined as a quantity and can differ significantly across institutions. This refers to both mathematical definitions and practical parameterisation and implementation. An extreme example of this is that some institutions do not price CVA into trades nor include it in their accounts. More subtle examples involve the use of historical or market implied parameters, choice over including DVA and assumptions around closing out trades in the event of a counterparty default. Whilst future accounting standards and regulatory capital rules appear likely to create more uniformity over CVA quantification, it is not clear how rapid and complete the convergence will be. With the above in mind, the current paper aims to define the differences in CVA approaches between different institutions and also within the same institution. We explain how future accounting and regulatory requirements are likely to create a convergence but also highlight aspects that will create on going divergence. Two banks, two different CVAs There exist very different practices within the market when institutions calculate CVA charges. This is driven largely by current accounting standards which are not precise about if and how CVA should be accounted for. For example, if two banks are in competition on a trade, the following components may explain why their pricing in relation to CVA may be different: Risk mitigants. With respect to netting and collateral, different institutions see a different trade populations and collateral (CSA) terms. For this reason, risk mitigants will have different impacts and create different prices. Extreme examples of this are trade unwinds (where all other things being equal the original counterparty should give the most competitive price due to netting benefits) and first trades (where the counterparty with no existing trades should give the worst price). Note that this is a completely realistic reason for prices being divergent. No or limited CVA treatment. Although increasingly less common, it is still possible that banks may not charge CVA or may knowingly reduce CVA charges so as to win a trade even at a CVA induced loss 1. Modelling assumptions. Different modelling assumptions lead to different prices. This will include choices over multi factor models, smile approaches and also the treatment of subjective components such as collateral and break clauses 2. Parameter assumptions. Even within the same model, different parameter assumptions for calibration will create price divergence. The most significant difference here comes in the choice of real world vs. riskneutral parameters. In particular, real world default probabilities (for example, driven by ratings) tend to be significantly smaller than risk neutral (driven by credit spreads) values. DVA and FVA. Finally, choices over the use of DVA and FVA (funding value adjustment) create price divergence. For example, DVA can be seen as reducing CVA charges and would lead to the more risky institutions being the most aggressive in pricing counterparty risk. With the exception of risk mitigants (and potentially FVA), the above differences between CVA calculations do not have any economic reality. Future changes to regulatory capital rules and accounting standards appear to create forces of convergence and may lead to more uniformity. For example, IFRS13 and Basel III lead towards risk neutral parameters, in some cases explicitly. However, IFRS13 and Basel III are discordant on the treatment of DVA. This leads to a further consideration, which is to what degree different definitions of CVA different even within a single institution. 1 One example of this latter effect is charging less CVA on cross currency swaps under the assumption that this will be balanced by profits on shorter dated FX trades with the same client. 2 For example, optional or rating linked. 2

One bank, three different CVAs Within a bank, there may exist multiple definitions of CVA. The most obvious would be accounting CVA (for books and records), front office CVA (for pricing new transactions) and regulatory CVA (for defining capital requirements). This is particularly important to consider as misalignment between CVA definitions can lead to poor trading decisions, incorrect assessment of risk and mismanagement of capital. For example, if accounting and front office CVA definitions do not match then apparently profitable trades may not appear that way to shareholders and PnL volatility as seen by a CVA desk may not be equivalently represented in earnings volatility. Another example would be that if front office and regulatory CVA were misaligned then a reduction in capital may increase CVA volatility and vice versa (for more discussion on this point see our whitepaper last month entitled CVA Capital Charges: A Comparative Analysis ). CVA definition may differ for both fundamental and regulatory reasons. The differences are summarised in Table 1: Accounting Front office (for trade pricing) Regulatory (CVA VAR) Default Probability Exposure DVA Exceptions If CVA is seen as a reserve then real world: Currently Possible o Historical (or blended) default probabilities mandatory (FAS exceptions: o Historical volatilities and correlations 157) or optional If CVA is seen as a market price then risk neutral: (IAS39) Collateralised o Credit spread implied default probabilities Future IFRS 13 counterparties o Market implied volatilities and correlations (where requirements Short dated available) imply DVA is trades Current accounting rules (IAS 39 / FAS 157) do not give mandatory Central cleared clear direction (CCP) trades IFRS 13 requirements over exit price imply a risk neutral High credit approach (particularly relevant for the calculation of quality default probabilities) counterparties Potentially risk neutral (spread based) even if bank s accounting CVA is defined historically May charge based on historical (or blended) but then ignore DVA Risk neutral (Basel III clearly defines CVA with respect to credit spreads) Mapping methods are important Typically risk neutral exposure Real world simulation if used will probably be a facet of using older PFE type systems for CVA calculations Real world parameters for simulation (IMM), or implicit in other methods (e.g. CEM) Risk neutral approach a consideration for IMM banks to give better alignment Stressed VAR component creates misalignment Need to assume fixed EAD for CVA VaR creates misalignment as related hedges do not achieve capital relief Typical price will include some (but not all) of the DVA (not with real world default probabilities) Not allowed (no DVA offset in calculation of CVA VAR) Only possible exceptions are: CCPs European Sovereign exemptio n (CRD IV) Table 1. Comparison of different CVA definitions as they apply to OTC derivatives. 3

We discuss the different CVA definitions in more detail below: Default probability. A major classical split in CVA practice has always existed in defining default probabilities where both real world (historical 3 ) and risk neutral (spread based) have been deemed acceptable under accounting requirements. To some degree the difference is definitional since real world approaches view CVA as a reserve or provision whereas risk neutral calculations define it as a market price with DVA typically used as an offset. Nevertheless, this point is still controversial as historical default probabilities tend to give much lower CVA numbers. Typically, large banks with more significant OTC derivatives exposures have tended to follow a risk neutral approach. Looking forward, where robust frontoffice CVA pricing is implemented, it tends more commonly to use risk neutral default probabilities so as to be market based. Within an institution (at least for a period of time), accounting CVA may often lag behind front office pricing approaches and be more historically based. Basel III capital requirements and IFRS 13 accounting requirements define default probabilities as risk neutral and spread mapping procedures for illiquid names are therefore important. It seems likely that such changes will drive CVA to be consistently defined as being spread based, irrespective of the liquidity of the underlying credit derivative market. Exposure. The distinction between using real world and risk neutral exposure is less significant than the similar default probability definition. This is partly because the differences tend to be less severe and partly because in some cases choice does not occur. With respect to the latter point, drifts are normally calibrated to forward rates 4 and correlation and some volatilities often have to be estimated as real world (historical) parameters since there are no relevant market traded instruments. Front office pricing will always tend to be based on risk neutral parameters where possible so as to align with hedging. Whilst there is flexibility in both accounting and Basel III capital requirements, use of risk neutral exposure here would appear to be more obvious so as to produce alignment. However, a bank would need to be under the advanced approach to expect a reasonable alignment for capital purposes and even then would have to use a stressed risk neutral calibration which creates a unbridgeable gap between regulatory/front office and Basel III exposure (see aforementioned whitepaper CVA Capital Charges: A Comparative Analysis ). Finally, the requirement to fix EAD in the CVA VaR calculation creates the problem that CVA market risk hedges (e.g. interest rate, FX) that reduce CVA PnL volatility actually cause increases in CVA capital. 5 DVA. Not all banks use DVA in accounting and some do not include it in front office pricing although, as noted above, this would generally be tempered by using historical or blended default probabilities. At the time of writing, US and Canadian banks (FAS 157) are required to account for DVA whilst European banks (IAS 39) are not. Future accounting rules under IFRS 13 require DVA to be included but, on the other hand, Basel III capital rules clearly state that DVA benefits must not be included. 6 Front office pricing often falls between the extremes of accounting and capital definitions with some, but not all, of the DVA component included and capped by the CVA component so as not to pay more than the risk free price (paying through mid) for a trade. The treatment of DVA in pricing would also depend on the trade type, presence of a collateral agreement and sophistication of the counterparty in question. Exceptions. CVA across a portfolio is very heterogeneous with the CVA of a bank concentrated mainly over a relatively small proportion of trades and counterparties. For this reason, accounting and front office CVA may focus on only a proportion of a total portfolio with well collateralised 7 or short dated trades and those with high credit quality counterparties often ignored. Regulatory requirements, on the other hand, do not permit such sweeping exceptions with only central cleared trades and certain other specific exemptions 8 allowed. Notably, collateralised OTC trades, often ignored elsewhere must be capitalised. 3 Sometimes blended default probabilities may be used which are historically based but with some risk premium component derived from credit spreads also included. 4 On the basis that estimating real world drifts equates to predicting the future. 5 We note this is not related to CVA definition per se but rather to a simplification in representing the dynamic movement of CVA through time. 6 Application of own credit risk adjustments to derivatives consultative document, Basel Committee on Banking Supervision, http://www.bis.org/press/p111221.htm and http://www.bis.org/press/p120725b.htm. 7 Meaning typically collateral agreement with small thresholds. 8 A significant example being the European sovereign exemption for the CVA capital charge under CRD IV. Other exemptions, such as for nonfinancial exposures are being lobbied for. 4

Summary In this paper, we have described how definitions and quantification of CVA can differ both across different institutions and also within an institution. Despite the large amount of focus around CVA valuation and management, CVA itself can vary substantially in ways which do not have any solid economic rationale. Clearly, a convergence of market practices is needed. Firstly, all other things being equal, CVA charging and accounting across different institutions should be consistent. Secondly, the definition of CVA within an institution for different purposes should be equivalent so as to produce alignment between accounting, front office PnL and regulatory capital charges. Whilst future accounting and regulatory capital requirements due for implementation in 2013 seem to aid the standardisation of CVA components and convergence of market standards, only time will tell how rapid and complete this transformation will be. 5

Contact us Solum Financial 12 Austin Friars City of London EC2N 2HE United Kingdom +44 207 786 9230 research@solum financial.com Solum Financial Limited is authorised and regulated by the Financial Services Authority Jon Gregory Partner jon@solum financial.com +44 207 786 9233 Rowan Alston Senior Consultant rowan@solum financial.com +44 207 786 9238 Bernard Stroobandt Senior Consultant bernard@solum financial.com +44 207 786 9241 Nicolas Gakwaya Senior Consultant nicolas.gakwaya@solum financial.com +44 207 786 9234 Thu Uyen Nguyen Partner tu@solum financial.com +44 207 786 9231 Vincent Dahinden CEO vincent@solum financial.com +44 207 786 9235 6

About Solum Solum Financial is a consulting firm consisting of front office experts who provide advice and services on investment banking matters to both the sell side and buy side. We understand how both the front and back office operate and so are able to offer independent and uncompromised advice in both divisions, bridging the gap between the two with our extended knowledge and wealth of senior level experience. Solum Disclaimer This paper is provided for your information only and does not constitute legal, tax, accountancy or regulatory advice or advice in relation to the purpose of buying or selling securities or other financial instruments. No representation, warranty, responsibility or liability, express of implied, is made to or accepted by us or any of our principals, officers, contractors or agents in relation to the accuracy, appropriateness or completeness of this paper. All information and opinions contained in this paper are subject to change without notice, and we have no responsibility to update this paper after the date hereof. The valuation of derivatives and other financial securities are subject to general best market practice but a level of valuation uncertainty is unavoidable. This report may not be reproduced or circulated without our prior written authority. 7